Angiotensin II differentially induces matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 production and disturbs MMP/TIMP balance

Avicenna Journal of Medical Biotechnology

Volumn 2, Issue 2, 2010, Pages 79-85

  Yaghooti, Hamid ^a   Firoozrai, Mohsen ^a   Fallah, Soudabeh ^a   Khorramizadeh, Mohammad Reza ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin II; Matrix metalloproteinase 9; Monocytic cell; Tissue inhibitor of metalloproteinase 1

Indexed keywords

ANGIOTENSIN II; GELATINASE B; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; STIMULATION; SUPERNATANT; ZYMOGRAPHY;

EID: 77954833560     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:82-97.
2. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 2002;89(2):3A-9A.
3. Cheng ZJ, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit 2005;11(6):RA194-205.
4. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002;90:251-262.
5. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitor of metalloproteinases. Circ Res 2003;92:827-839.
6. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75(2):346-359. (Pubitemid 350298459)
7. Li YY, Feldman AM, Sun Y, McTiernan CF. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 1998;98:1728-1734. (Pubitemid 28492492)
8. Browatzki M, Larsen D, Pfeiffer CAH, Gehrke SG, Schmidt S, Kranzhofer A, et al. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-κB and activator protein-1 in a redox sensitive manner. J Vasc Res 2005;42(5):415-423.
9. Wang TL, Yang YH, Chang H, Hung CR. Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway. J Mol Cell Cardiol 2004;37(3):785-794. (Pubitemid 39194570)
10. Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, et al. Angiotensin II induces MMP-2 in a p45phox-dependent manner. Biochem Biophys Res Commun 2005;328(1):183-188.
11. Kim MP, Zhou M, Wahl LM. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. J Leukoc Biol 2005;78:195-201. (Pubitemid 40979958)
12. Kanome T, Watanabe T, Nishio K, Takahashi K, Hongo S, Miyazaki A. Angiotensin II upregulates acyl- CoA: cholesterol acyltransferase-1 via the angiotensin II type 1 receptor in human monocytemacrophages. Hypertens Res 2008;31(9):1801-1810.
13. Rezaei A, Ardestani SK, Forouzandeh M, Tavangar SM, Khorramizadeh MR, Payabvash S, et al. The effects of N-acetylcysteine on the expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in hepatic fibrosis in bile duct ligated rats. Hepatol Res 2008;38(12):1252-1263.
14. Fielitz J, Leuschner M, Zurbrugg HR, Hannack B, Pregla R, Hetzer R, et al. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med 2004;82(12):809-820.
15. Yang D, Ma S, Li D, Tang B, Yang Y. Angiotensin II receptor blockade improves matrix metalloproteinases/tissue inhibitor of matrix metalloproteinase-1 balance and restores fibronectin expression in rat infarcted myocardium. Biochem Biophys Res Commun 2009;388(3):606-611.
16. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G. Human monocytederived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;92(6):1565-1569.
17. Fotheringham JA, Mayne MB, Grant JA, Geiger JD. Activation of adenosine receptors inhibits tumor necrosis factor - alpha release by decreasing TNF-alpha mRNA stability and p38 activity. Eur J Pharmacol 2004;497(1):87-95.
18. Yuan ZY, Nimata M, Okabe T, Shioji K, Hasegawa K, Kita T, et al. Olmesartan, a novel AT(1) antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol Heart Circ Physiol 2005;289:H1147-1152.
19. Vincenti MP, Brinckerhoff CE. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J Cell Physiol 2007;213:355-364.
20. Fiotti N, Altamura N, Fisicaro M, Carraro N, Uxa L, Grassi G, et al. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:1330-1336.
21. Castoldi G, di Gioia CRT, Travaglini C, Busca G, S Redaelli, Bombardi C, et al. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect. Clin Experi Pharmcol Physiol 2007;34(3):205-209. (Pubitemid 46148263)
22. Chua CC, Hamdy RC, Chua BHL. Angiotensin II induces TIMP-1 production in rat heart endothelial cells. BBA-Mol Cell Res 1996;1311(3):175-180.
23. Zhang W, Zhong M, Yang G, Li JP, Guo C, Wang Z, et al. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme. Cardiovasc Pathol 2008;17(6):399-409.
24. Wang XD, Chen XM, Wang JZ, Hong Q, Feng Z, Fu B, et al. Signal transducers and activators of transcription 3 mediates up-regulation of angiotensin II-induced tissue inhibitor of metalloproteinase-1 expression in cultured human senescent fibroblasts. Chin Med J 2006;119(13):1094-1102.
25. Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta P, et al. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998;18:1433-1439. (Pubitemid 28421881)